Back
Ascendis Pharma AS Stock Price Chart
Sponsored
ASND
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
20
ASND
Ascendis Pharma AS
Last Price:
123.21
Seasonality Move:
20.86%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing slight buying pressure.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.5 | Sell |
20-day SMA: | 126.25 | Sell |
50-day SMA: | 132.55 | Sell |
200-day SMA: | 136.92 | Sell |
8-day EMA: | 124.99 | Sell |
20-day EMA: | 126.65 | Sell |
50-day EMA: | 129.84 | Sell |
200-day EMA: | 130.32 | Sell |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.98 | Sell |
Relative Strength Index (14 RSI): | 44.33 | Sell |
Chaikin Money Flow: | 89072 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.33 - 129.33) | Sell |
Bollinger Bands (100): | (124.53 - 141.57) | Sell |
Ascendis Pharma AS Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
- Ascendis Pharma AS share price is 124.38 while ASND 8-day simple moving average is 125.50, which is a Sell signal.
- The stock price of ASND is 124.38 while Ascendis Pharma AS 20-day SMA is 126.25, which makes it a Sell.
- Ascendis Pharma AS 50-day simple moving average is 132.55 while ASND share price is 124.38, making it a Sell technically.
- ASND stock price is 124.38 and Ascendis Pharma AS 200-day simple moving average is 136.92, creating a Sell signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
20
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a Sell
The current Ascendis Pharma AS [ASND] share price is $124.38. The Score for ASND is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
7.43B
Price in USD:
124.38
Share Volume:
304.17K
Ascendis Pharma AS 52-Week Range
52-Week High:
161.00
52-Week Low:
90.13
Sell
20
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?
The Ascendis Pharma AS stock price is 124.38 USD today. -
Will ASND stock go up or go down?
Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators -
Is Ascendis Pharma AS overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
- Ascendis Pharma AS share price is 124.38 while ASND 8-day exponential moving average is 124.99, which is a Sell signal.
- The stock price of ASND is 124.38 while Ascendis Pharma AS 20-day EMA is 126.65, which makes it a Sell.
- Ascendis Pharma AS 50-day exponential moving average is 129.84 while ASND share price is 124.38, making it a Sell technically.
- ASND stock price is 124.38 and Ascendis Pharma AS 200-day simple moving average is 130.32, creating a Sell signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
- ASND Moving Average Covergence Divergence (MACD) indicator is -1.98, suggesting Ascendis Pharma AS is a Sell
- Ascendis Pharma AS Relative Strength Index (RSI) is 44.33, which suggest Ascendis Pharma AS is oversold
- The Bollinger Bands (25) for Ascendis Pharma AS is (124.33 - 129.33), which suggest Ascendis Pharma AS is a Sell
- The Bollinger Bands (100) for Ascendis Pharma AS is (124.53 - 141.57), which suggest Ascendis Pharma AS is a Sell
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.